Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Guillot, A. Carré, S. Gabor, E. Tron, C. Mireille, F. Delphine, C. Annick, P. Michel, E. Ralph (Paris, Basel, France; Paris, Switzerland). Two new NKX2-1 mutations associated with pediatric interstitial lung diseases. Eur Respir J 2009; 34: Suppl. 53, 4767

Member's Comments

No comment yet.

Related content which might interest you: Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3G964A Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005 Interstitial lung disease in patients with connective tissue diseases - a report of 3 cases Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 Interstitial lung diseases in infants and children Source: Eur Respir J 2008; 31: 658-666 Year: 2008 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 SFTPA mutations in interstitial lung disease (ILD) and lung cancer Source: International Congress 2017 – Rare diseases Year: 2017 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs) Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017 Year: 2017 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Homeobox-genes (HOX) in human lung - altered expression in lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001 The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018